Trial Profile
A Phase 2 Study of ET-743 in Subjects With Advanced Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2011
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary) ; Dexamethasone
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 07 Apr 2011 New trial record